52w high/low | ₹13.89 / ₹5.51 |
P/E ratio | -22.87 |
Dividend | 0 |
ROE | 5.73 |
ROCE | -5.09 |
Face value | 10 |
Book value | ₹-14.28Cr |
Market capital | ₹18.75Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Incorporated on 7 Sep. '90 as a private limited company and promoted by B N Thakore, N J Patel and N L Upadhyaya, Norris Medicines is purely a pharmaceutical formulations-based company. It became a public limited company in Mar. '92. Commercial production of the formulation unit commenced in Nov. '91. The company came out with a public issue aggregating Rs 5 cr in Dec. '93 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit.